Search

Search Constraints

You searched for: Author/Creator Heshmat, Saman

Search Results

3. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. Issue 10 (29th April 2018)

4. Incidence and prevalence of NMOSD in Australia and New Zealand. Issue 8 (26th May 2017)

5. Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis. Issue 42 (22nd October 2021)

6. Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis. Issue 42 (22nd October 2021)